Insights
Newsletters
European Antitrust Bimonthly Bulletin – May/June 2026
The firm is pleased to distribute the European Antitrust Bimonthly Bulletin, which distills the major antitrust developments in Europe over the past two months into concise and actionable takeaways. Companies operating in, or transacting with, Europe should take note of this quarter's developments in merger enforcement, digital markets regulation, and AI-related antitrust scrutiny.
Newsletters
All Eyes on AI: Regulatory, Litigation, and Transactional Developments – Q1 2026
Wilson Sonsini is pleased to present the next edition of All Eyes on AI: Regulatory, Litigation, and Transactional Developments, which closely follows the evolving regulatory landscape for artificial intelligence (AI) in the U.S., new EU regulations for AI, international developments, litigation, recent deal highlights, firm publications, and other AI and machine learning highlights.
Newsletters
The Life Sciences Report – June 2026
This latest edition features articles on accelerating new therapies under the new FDA administration, cash-pay healthcare companies possibly facing kickback and fee-splitting risk under federal and state laws, building in-house legal teams for biotech, digital health, and medical devices companies, and life sciences venture financings for firm clients across 1H2025 and 2H2025.
All Results
News Articles
8.20.26
Ariel Green Anaba Named to Daily Journal's 2026 "Top 40 Under 40"
Wilson Sonsini litigation partner Ariel Green Anaba has been named to Daily Journal's 2026 "Top 40 Under 40," recognizing California's leading litigators under age 40.
News Articles
8.20.26
Five Wilson Sonsini Attorneys Named 2027 “Lawyer of the Year” Honorees by Best Lawyers
Five Wilson Sonsini attorneys have been named 2027 “Lawyer of the Year” honorees by The Best Lawyers in America®, one of the publication’s highest peer-reviewed distinctions. The honors span five practice areas and three markets and recognize Caz Hashemi, Martin W. Korman, Martin J. Waters, Patrick J. Schultheis, and Craig E. Sherman.
Alerts
8.20.26
U.S. Commerce Department Streamlines Drone Export Controls
Late last week, the U.S. Commerce Department’s Bureau of Industry and Security (BIS) issued its long-anticipated rule to streamline export controls applicable to commercial and dual-use unmanned aerial vehicles (UAVs): Streamlining Export Controls for Drone Exports, 91 Fed. Reg. 52,501 (Aug. 14, 2026) (the Rule). While the Rule loosens controls on many commercial UAVs with lower endurance, the Rule also enhances controls in a few key areas.
Client Highlights
8.20.26
Wilson Sonsini Advises Highspot on Merger with Seismic
On August 18, 2026, Seismic, an AI-powered sales and revenue enablement platform, announced the completion of its merger with Highspot. Following a second request review, the merger obtained U.S. antitrust clearance, which allowed the transaction to close without any action by the Department of Justice Antitrust Division. The combined company will operate under the Seismic name and be led by Seismic Chief Executive Officer Rob Tarkoff. Wilson Sonsini Goodrich & Rosati advised Highspot on the transaction.
Press Releases
8.20.26
Wilson Sonsini Welcomes Former Couchbase Chief Legal Officer Margaret Chow to General Counsel in Residence Program
Contact:
Kimberly Brooks
212-453-2881
kbrooks@wsgr.com
Kimberly Brooks
212-453-2881
kbrooks@wsgr.com
News Articles
8.19.26
Doyle’s Guide Recognizes Jocelyn Chow as Leading Competition & Antitrust Lawyer
Wilson Sonsini partner Jocelyn Chow has been recognized by Doyle’s Guide in its “Leading Competition & Antitrust Lawyers – Hong Kong 2026” list as a Leading practitioner. Doyle’s Guide is an independent legal rankings publication covering major Asia-Pacific and international markets. Its rankings are based on independent research, including peer-review surveys and interviews with clients, peers, and relevant industry bodies, with Leading practitioners recognized for consistently drawing praise from clients and peers.
Alerts
8.18.26
CalPrivacy Authorizes Rulemaking on Opt-Out Signals, Raises Data Broker Fees, and Starts the Clock on DROP Amendment Comment Period
At its August 6–7, 2026, board meetings, the California Privacy Protection Agency (CalPrivacy) Board directed staff to prepare formal rulemaking to name Global Privacy Control (GPC) in the California Consumer Privacy Act (CCPA) regulations and tighten how opt-out preference signals must be honored. It also advanced separate rulemaking on data broker deletion audits and Delete Request and Opt-out Platform (DROP) rule amendments. Finally, the Board raised annual data broker registration and DROP access fees from $6,000 to $9,500 for 2027 and previewed its audit program.
Alerts
8.18.26
CMS Proposes Changes to Incentivize FHIR-enabled Electronic Prior Authorization Use
On July 14, 2026, the Centers for Medicare & Medicaid Services (CMS) announced the CY 2027 Physician Fee Schedule (PFS) proposed rule. The proposed rule includes modifications to further incentivize the use of electronic prior authorization in Medicare Ambulatory Specialty Models (ASMs) and the Merit-based Incentive Payment System (MIPS) by health care providers. This builds on prior CMS regulations related to prior authorization which imposed requirements on certain health plans, but not on health care providers (see 2024 CMS Interoperability and Prior Authorization final rule). These changes are not “PFS” in the technical sense of altering relative value unit (RVU) or conversion-factor payment calculations, but rather are Quality Payment Program (QPP) and Center for Medicare and Medicaid Innovation (CMMI) policy changes that are included in the same omnibus annual rulemaking package. For CMS’s proposed PFS and Hospital Outpatient Prospective Payment System (OPPS) payment changes, see our previous client alert, “Health Reimbursement Signals: CMS Proposes Payment Frameworks for ‘Software as a Medical Service.’”1
News Articles
8.18.26
In Memoriam: Wilson Sonsini Remembers Maya Skubatch
The firm is saddened to share that longtime Wilson Sonsini partner Maya Skubatch recently passed away following a courageous battle with blue nevus melanoma, an extremely rare form of cancer. She is survived by her husband, Amit Litsur, their three teenage children, and her parents, among many others. We offer our deepest condolences to her family, friends, and colleagues.Client Highlights
8.18.26
Wilson Sonsini Advises InduPro on $77 Million Series B Financing
On August 12, 2026, InduPro, Inc., a biotechnology company defining membrane protein spatial relationships to create novel therapeutics for the treatment of cancer and autoimmune diseases, announced the closing of a $77 million Series B financing led by The Column Group, with participation from Vida Ventures, MRL Ventures Fund, Emerson Collective (advised by Yosemite), Euclidean Capital, Solasta Ventures, Sanofi, and Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati advised InduPro on the transaction.
Client Highlights
8.17.26
Firm Advises Gravis Robotics on $200 Million Series A
On August 17, 2026, Gravis Robotics, a company retrofitting construction machines with autonomous technology, announced their Series A financing, with SoftBank investing $200 million in the company. The funding is the largest Series A in construction robotics history and will be used to scale autonomous machinery, bringing physical artificial intelligence (AI) directly to construction sites and embedding autonomous systems into heavy machinery fleets. Wilson Sonsini Goodrich & Rosati advised Gravis on the transaction.